Skip to main content

TFF Pharmaceuticals, Inc.

TFFPDelisted Mar 6, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001733413

TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in TFF Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
+1 vs. Q2 2022
Shares held
4.23M
+1.04M (+32.7%) vs. Q2 2022
Total value
$17.2M
−$837.0K (−4.6%) vs. Q2 2022
New holders
6
15 more added
Sold out
5
10 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TFFP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 45 institutions
Q1 2021: 63 institutionsQ2 2021: 60 institutionsQ3 2021: 54 institutionsQ4 2021: 51 institutionsQ1 2022: 43 institutionsQ2 2022: 45 institutionsQ3 2022: 45 institutionsQ4 2022: 41 institutionsQ1 2023: 36 institutionsQ2 2023: 33 institutionsQ3 2023: 41 institutionsQ4 2023: 23 institutionsQ1 2024: 19 institutionsQ2 2024: 21 institutionsQ3 2024: 23 institutionsQ4 2024: 4 institutionsQ1 2025: 3 institutionsQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ3 2022: $17.2M
Q1 2021: $96.1MQ2 2021: $54.5MQ3 2021: $45.1MQ4 2021: $41.1MQ1 2022: $27.1MQ2 2022: $23.7MQ3 2022: $17.2MQ4 2022: $7.52MQ1 2023: $4.80MQ2 2023: $3.02MQ3 2023: $4.04MQ4 2023: $2.45MQ1 2024: $2.12MQ2 2024: $1.07MQ3 2024: $1.48MQ4 2024: $196Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TFFP and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20251$0
Q1 20253$0
Q4 20244$196
Q3 202423$1.48M
Q2 202421$1.07M
Q1 202419$2.12M
Q4 202323$2.45M
Q3 202341$4.04M
Q2 202333$3.02M
Q1 202336$4.80M
Q4 202241$7.52M
Q3 202245$17.2M
Q2 202245$23.7M
Q1 202243$27.1M
Q4 202151$41.1M
Q3 202154$45.1M
Q2 202160$54.5M
Q1 202163$96.1M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding TFF Pharmaceuticals, Inc.; share changes are against Q2 2022.

Institutions holding TFFP in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Steward Partners Investment Advisory, LLC100$00.00%00.0%Unchanged
Royal Bank of Canada614$2.00K0.00%+114+22.8%Added
Cutler Group LP1,000$4.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,000$4.00K0.00%+1,000New
HM Payson & Co1,500$6.00K0.00%00.0%Unchanged
Morgan Stanley2,023$8.00K0.00%−4,940−70.9%Reduced
Parallel Advisors, LLC2,963$12.0K0.00%00.0%Unchanged
Selective Wealth Management, Inc.3,200$13.0K0.01%−1,800−36.0%Reduced
Simplex Trading, LLC3,213$13.0K0.00%+3,213New
Bank of America Corp3,607$15.0K0.00%−4,317−54.5%Reduced
Tower Research Capital LLC (TRC)4,418$18.0K0.00%−328−6.9%Reduced
Newbridge Financial Services Group, Inc.5,000$20.0K0.01%+1,000+25.0%Added
Caption Management, LLC5,000$21.0K0.00%+5,000New
Venturi Wealth Management, LLC8,273$34.0K0.00%+8,273New
Baldwin Brothers Inc10,000$41.0K0.01%00.0%Unchanged
Quantum Private Wealth, LLC11,082$44.0K0.03%00.0%Unchanged
Meridian Wealth Advisors, LLC11,500$47.0K0.01%00.0%Unchanged
Charles Schwab Investment Management Inc11,966$49.0K0.00%00.0%Unchanged
Qube Research & Technologies Ltd19,663$80.0K0.00%+3,358+20.6%Added
Sanders Morris Harris LLC20,826$83.0K0.02%00.0%Unchanged
Virtu Financial LLC20,776$84.0K0.01%+20,776New
University of Texas/Texas Am Investment Managment Co22,066$90.0K0.03%00.0%Unchanged
Price T Rowe Associates Inc22,700$93.0K0.00%00.0%Unchanged
Stifel Financial Corp24,200$98.0K0.00%−900−3.6%Reduced
National Asset Management, Inc.27,800$113.0K0.00%−4,000−12.6%Reduced
Fermata Advisors, LLC27,804$113.0K0.04%+205+0.7%Added
Wells Fargo & Company29,094$119.0K0.00%+7,425+34.3%Added
Northern Trust Corp39,108$159.0K0.00%+4,348+12.5%Added
Mesirow Financial Investment Management, Inc.40,013$162.0K0.77%00.0%Unchanged
Raymond James & Associates47,450$193.0K0.00%+3,400+7.7%Added
Westside Investment Management, Inc.51,975$211.0K0.00%+325+0.6%Added
Citadel Advisors LLC54,265$221.0K0.00%−5,947−9.9%Reduced
Bridgeway Capital Management, LLC58,700$238.0K0.01%−20,800−26.2%Reduced
Susquehanna International Group, LLP66,511$270.0K0.00%+16,763+33.7%Added
State Street Corp69,929$284.0K0.00%00.0%Unchanged
Sigma Planning Corp76,891$312.0K0.01%+300+0.4%Added
UBS Group AG97,609$396.0K0.00%+5,432+5.9%Added
Princeton Capital Management LLC136,574$554.0K0.24%+3,138+2.4%Added
Geode Capital Management, LLC188,334$764.0K0.00%+3,012+1.6%Added
BlackRock Inc.259,136$1.05M0.00%−1,854−0.7%Reduced
Carlson Capital L P275,000$1.12M0.08%−25,000−8.3%Reduced
Gagnon Securities LLC284,830$1.16M0.25%+469+0.2%Added
Sepio Capital, LP315,060$1.28M0.13%+217,360+222.5%Added
Vanguard Group Inc868,431$3.53M0.00%00.0%Unchanged
DRW Securities, L.L.C.1,000,000$4.06M1.27%+1,000,000New
Gsa Capital Partners LLP0$00.00%−93,679−100.0%Sold out
JPMorgan Chase & Co0$00.00%−43,133−100.0%Sold out
Group One Trading, L.P.0$00.00%−37,273−100.0%Sold out
PDT Partners, LLC0$00.00%−17,051−100.0%Sold out
Citigroup Inc0$00.00%−500−100.0%Sold out
DRW Securities, LLC––––Not filed